Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.

MLA

Omori-Mizuno, Yoshie, et al. “Randomized Study Comparing Vitamin D3 and 1α-Hydroxyvitamin D3 in Combination with Pegylated Interferon/Ribavirin Therapy for Chronic Hepatitis C.” Journal of Gastroenterology and Hepatology, vol. 30, no. 9, Sept. 2015, pp. 1384–90. EBSCOhost, https://doi.org/10.1111/jgh.12949.

APA

Omori-Mizuno, Y., Nakayama, N., Inao, M., Funyu, J., Asabe, S., Tomita, K., Nishikawa, K., Hosoda, Y., Tanaka, M., Hashimoto, Y., Yakabi, K., Koshima, Y., & Mochida, S. (2015). Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C. Journal of Gastroenterology and Hepatology, 30(9), 1384–1390. https://doi.org/10.1111/jgh.12949

Chicago

Omori-Mizuno, Yoshie, Nobuaki Nakayama, Mie Inao, Junji Funyu, Shinichi Asabe, Kengo Tomita, Kou Nishikawa, et al. 2015. “Randomized Study Comparing Vitamin D3 and 1α-Hydroxyvitamin D3 in Combination with Pegylated Interferon/Ribavirin Therapy for Chronic Hepatitis C.” Journal of Gastroenterology and Hepatology 30 (9): 1384–90. doi:10.1111/jgh.12949.